布格替尼 布加替尼 安伯瑞 (Lucius)
布加替尼用于治疗克唑替尼治疗后病情进展或不耐受的ALK阳性非小细胞肺癌患者。
- The description claims that Brigatinib has 12 times higher inhibition of ALK compared to Crizotinib.
Specifications
- 通用名称
- Brigatinib, 布格替尼
- 剂型
- 片剂
- 剂量
- 180mg, 90mg
AI Readiness
Good foundation, but some important product data is still missing.
69%